Final Glance: Pharmaceuticals companies
AP - Wed Jun 18, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were up at the close of trading:
Final Glance: Medical Devices companies
AP - Wed Jun 18, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were up at the close of trading:
Medtronic vs. Johnson & Johnson: Meet the Market's Biggest New Rivalry
Dan Carroll, The Motley Fool - Motley Fool - Wed Jun 18, 4:10PM CDT
Medtronic 's earth-shaking buy of rival medical device leader Covidien for nearly $43 billion this week didn't just add a new arsenal of products and cash flows to the company's portfolio; the deal also rocked the med-tech landscape. Smaller and...
In odd twist, industry agrees to ban 'microbeads'
By JOHN FLESHER - AP - Wed Jun 18, 3:58PM CDT
TRAVERSE CITY, Mich. (AP) — Environmentalists in Illinois expected a battle royal over their call for a statewide ban on "microbeads" — tiny bits of plastic used in personal care products such as facial scrubs and toothpaste that are flowing by the billions into the Great Lakes and other waterways. Discovered only recently, they're showing up inside fish that are caught for human consumption, scientists say.
Midday Glance: Medical Devices companies
AP - Wed Jun 18, 1:17PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Wed Jun 18, 1:17PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Early Glance: Medical Devices companies
AP - Wed Jun 18, 10:36AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Early Glance: Pharmaceuticals companies
AP - Wed Jun 18, 10:36AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Construction Specialties Receives Sixth Consecutive Champion for Change Award
PRWeb - Wed Jun 18, 9:18AM CDT
Construction Specialties (C/S), a leading manufacturer of high-performing commercial architectural building products such as Acrovyn Wall Protection, Acrovyn Door Systems, Pedisystems Entrance Flooring and C/S Expansion Joint Covers, is pleased to announce that it has been chosen to receive its sixth consecutive Champion for Change Award from Practice Greenhealth. C/S shares this impressive achievement with only one other manufacturer - Johnson & Johnson, makers of health care products and medical devices. The award was presented at CleanMed 2014 in Cleveland, OH, on June 5, 2014, and honors healthcare suppliers that have not only taken steps to improve their organization's green practices but have gone the extra mile to help their clients and associates expand their sustainable practices as well.
ERYTECH adds two new independent members to board
M2 - Wed Jun 18, 5:41AM CDT
ERYTECH Pharma (Paris:ERYP.PA), a French biopharmaceutical company, announced today the appointment of Dr Martine George and Hilde Windels as new independent members to its board of directors.
2014 Report on the International Ophthalmology Diagnostics and Surgical Devices Market - Forecasts to 2019
M2 - Wed Jun 18, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9rfpsb/ophthalmology) has announced the addition of the "2014 Report on the International Ophthalmology Diagnostics and Surgical Devices Market - Forecasts to 2019" report to their offering. Rapid developments in the field of ophthalmology has ensured introduction of efficient diagnosis and treatment methodologies that has rendered enhanced patient outcomes. The ophthalmology market is experiencing an impressive growth globally majorly due to tremendous increase in demand for novel diagnostic technological platforms and efficient treatment methodologies. The ophthalmology sector being an integral part of healthcare sector has witnessed huge growth in terms of scope as well as adoption by patient population owing to rapid technological advances. The speedy growth of the overall medical device industry is considered to be a major driving force for the growth of the ophthalmology diagnostics and surgical devices market. The report analyzes the global market for ophthalmology diagnostics and surgical devices market by three major segments namely, by product type, by applications and by geography. The product type segment has been further categorized into various types of diagnostic and surgical devices along with vision care products. While, the diagnostic devices market has been further classified into fourteen major devices namely, autorefractometers, slit lamps, tonometers, ophthalmoscopes, fundus cameras, fluorescein angiography, optical coherence tomography (OCT) systems, Echography systems, Keratometers, Gonioscopes, Pachymeters, perimeters, corneal topographers and specular microscopes. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global ophthalmology Devices Market, by Product Type Chapter 5 Global Ophthalmology diagnostics and Surgical Devices Market, by Application Chapter 6 Global Ophthalmology Diagnostics and Surgical Devices Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb, Inc. (Valeant Pharmaceuticals) - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/9r...thalmology
2014 Report on the International Human Reproductive Technologies Market - Forecast to 2019
M2 - Wed Jun 18, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d66cdt/human) has announced the addition of the "2014 Report on the International Human Reproductive Technologies Market - Forecast to 2019" report to their offering. This report covers the market analysis for various drugs, devices and treatment technologies used in assistance and to control human reproduction. The stakeholders for this study include manufacturers and providers of contraceptive technologies and infertility solutions. The market overview section of the report demonstrates the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global human reproductive technologies market. The global human reproductive technologies market is categorized on the basis of various infertility treatments and contraceptive technologies. The infertility technologies market is analyzed in this report with respect to drugs as well as types of treatment procedures. With respect to drugs, the report includes leading brands (by sales) from three major classes, namely, gonadotropins, androgens and erectile dysfunction. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Human Reproduction Technologies Market, by Infertility Treatment Chapter 5 Global Human Reproductive Technologies Market, by Contraceptive Technologies Chapter 6 Global Human Reproductive Technologies Market Revenue, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - Actavis, Inc. - Bayer AG - Church & Dwight, Co. Inc. - Cook Medical, Inc. - Ferring International Center S.A. - Johnson & Johnson - Merck & Co., Inc. - Merck Serono - Pfizer, Inc. - Reckitt Benckiser Group plc - Teva Pharmaceutical Industries Ltd. - Warner Chilcott plc For more information visit http://www.researchandmarkets.com/research/d66cdt/human
J&J's Velcade in Focus at the European Hematology Association - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 17, 4:20PM CDT
Johnson & Johnson (JNJ) presented encouraging data from a phase III study on its oncology drug, Velcade, at the annual meeting of the European Hematology Association.
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
PR Newswire - Tue Jun 17, 4:00PM CDT
Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 15th, to review second-quarter results. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Dominic Caruso, Vice President, Finance and Chief Financial Officer; Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson and Worldwide Chairman, Pharmaceuticals; Joaquin Duato, Worldwide Chairman, Pharmaceuticals; and Louise Mehrotra, Vice President, Investor Relations, will host the call.
Drugs Drive Growth For Johnson & Johnson
at Investor's Business Daily - Tue Jun 17, 3:58PM CDT
At 128 years old, Johnson & Johnson (JNJ) is still delivering growth and income for its shareholders. It's not Band-Aid bandages and baby oil that's driving growth for the New Brunswick, N.J.-based health-care giant. Out of its three operating units,...
Beck Expands Team With Experienced Director of Operations
PRWeb - Tue Jun 17, 3:04PM CDT
Beck, a print reproduction process authority specialized in enhancing a brand's image on the shelf or any media output, has expanded its executive leadership team with the addition of Jimmy Watkins as Director of Operations. Mr. Watkins brings more than 20 years of design and packaging commercialization expertise, and will be responsible for identifying and implementing process improvements to optimize a brand's color consistency and printed image.
ExxonMobil, Johnson & Johnson Tumble as Dow Gains
Dan Carroll, The Motley Fool - Motley Fool - Tue Jun 17, 1:39PM CDT
The market has struggled to stay on course today, and the Dow Jones Industrial Average beat back earlier losses to rise 35 points into the green as of 2:35 p.m. EDT. Twelve of the blue-chip index's 30 member stocks were in the red. ExxonMobil ...
3-D Printing Company Materialise Prices IPO and Is Expected to Begin Trading on June 24
Beth McKenna, The Motley Fool - Motley Fool - Tue Jun 17, 1:03PM CDT
The 3-D printing stocks have taken a bruising in 2014, but that's not stopping Belgium-based Materialise from throwing its hat into the publicly traded ring. IPO terms were released last week, so we can now explore these questions: Does this...